1 Evolution Bioscience | Kala Pharmaceuticals
';

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

Recent Comments

    Recent Posts

    • Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas April 12, 2018
    • All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation March 28, 2018

    RSS Unknown Feed

    Search

    Tag Cloud

    Agricultural Technology AstraZeneca Bayer Bio-Rad Biopharma Bioproduction Biotech bluebird bio Cancer Immunotherapy Celgene Cell Therapy Charles River Laboratories Chemicals CRO/CMO Diagnostics Drug Development Evolution Global Press Releases Evolution Infographics GE Healthcare Gene Therapy Genomics & Proteomics GSK Illumina Informatics & Analytics Johnson & Johnson Juno Therapeutics KITE Pharma Life Sciences Lonza Medical Devices Merck Mergers Partnerships & Acquisitions Metagenomics MilliporeSigma Next Generation Sequencing Novartis Pfizer Plant Impact Regenerative Medicine Roche Sanofi Sartorius Stedim Sigma-Aldrich The Future of BioManufacturing Thermo Fisher Scientific

    Text

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. In in lorem sit amet ligula feugiat vulputate vel vitae quam. Cras posuere imperdiet lorem, in aliquam urn

    CategoriesTitle

    • Evolution Infographics
    • News & Analysis

    ArchivesTitle

    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • October 2017
    • August 2017
    • July 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • March 2016
    • February 2016
    • January 2016
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • November 2014
    • October 2014

    Cat tabs

    First
    Second
    Third
    • Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
      Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
      All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
      All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
      Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
      Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
    • Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
      Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
      All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
      All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
    • Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
      Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
    +44 141 248 2026info@evolution-bio.comNewsletter Sign-UpDownload Our BrochureEvolution Executive Search
    logo
    Evolution Bioscience
    logo
    • Home
    • Clients & Core Services
    • News & Analysis
      • The Future of BioManufacturing
    • IPO Tracker

    Kala Pharmaceuticals

    Filter by:
    Categories
    • Evolution Infographics
    • News & Analysis
    Tags
    • 23andMe
    • 3M
    • A1M Pharma
    • Abcam
    • AbClon
    • Ablynx
    • Accenture
    • ACD Bio
    • Actelion
    • AdaptImmune
    • Advanced Scientifics
    • Advicenne
    • Aenova
    • Aesica
    • Affymetrix
    • Agilent Technologies
    • Agricultural Technology
    • Akcea Therapeutics
    • Alcami
    • Alcor
    • Alfa Aesar
    • Alkahest
    • Alligator Bioscience
    • Almac
    • Ambrosia
    • Amgen
    • AMRI
    • Annexin Pharmaceuticals
    • Applied Genetic Technologies
    • Applikon
    • argenx
    • Arysta LifeScience
    • AstraZeneca
    • Asymptote
    • Athenex
    • Atomwise
    • Avacta
    • Avalanche Biotechnologies
    • Avenue Therapeutics
    • AveXis
    • Avitide
    • AzurRx
    • Baxalta
    • Bayer
    • Bayer CropScience
    • BD Biosciences
    • Beckman Coulter
    • Benevolent AI
    • Berg Health
    • BerGenBio
    • Bio-Rad
    • Bio-Techne
    • Bioarctic B
    • Biogen
    • BioHaven Pharma
    • Bioinformatics
    • Biomanufacturing
    • Biomarin
    • BioOutsource
    • Biopharma
    • Bioproduction
    • BioReliance
    • Biotech
    • bluebird bio
    • Boehringer Ingelheim
    • Bonesupport
    • Bristol-Myers Squibb
    • Cambrex
    • Cancer Immunotherapy
    • Capsugel
    • CAR-T
    • CardioCell
    • Catalent
    • Celgene
    • Cell Line Engineering
    • Cell Therapy
    • Cell Therapy Ltd
    • Cellectis
    • Celsis International
    • Celyad
    • Cepheid
    • Charles River Laboratories
    • ChemChina
    • Chemicals
    • Clementia Pharmaceuticals
    • Clinical Diagnostics
    • Clinical Trials
    • CMC Biologics
    • Cognizant Technology Solutions
    • Consort Medical
    • Corning
    • Covance
    • CR Pharma
    • Crispr Therapeutics
    • CRO/CMO
    • Cryonics
    • Daiichi Sankyo
    • Danaher
    • Deciphera Pharmaceuticals
    • DeCODE Genetics
    • Deloitte
    • Denali Therapeutics
    • Dendreon
    • Diagnostics
    • Downstream Processing
    • Drug Development
    • eGenesis
    • Eli Lilly
    • Elsevier
    • EMD Millipore
    • Entegris
    • Eris Lifesciences
    • Erytech Pharma
    • Evidera
    • Evolution Global Press Releases
    • Evolution Infographics
    • Evotec
    • Exscientia
    • FEI Company
    • FiberCell Systems
    • FIT Biotech
    • Flow Cytometry
    • Fosun Pharma
    • Fujifilm Diosynth
    • G-CON Manufacturing
    • G1 Therapeutics
    • GE Healthcare
    • Gene Therapy
    • Genentech
    • Genomics & Proteomics
    • GenSight Biologics
    • Genzyme
    • Gilead
    • GlaxoSmithKline
    • Glycotope
    • Google Life Sciences
    • Gore
    • GSK
    • Healthcare Analytics
    • IBM
    • ICON plc
    • Idorsia
    • Illumina
    • Immunocore
    • Immuron
    • INC Research
    • InDex Pharma
    • Inflarx
    • Informatics & Analytics
    • Infosys
    • InSilico Medicine
    • InSphero
    • inVentiv Health
    • Invesco
    • IP Group
    • Isofol Medical
    • JHL Biotech
    • JM Separations
    • Johnson & Johnson
    • Juno Therapeutics
    • Juvenescence AI
    • Kala Pharmaceuticals
    • Kantar Health
    • Kerry Group
    • KITE Pharma
    • KIYATEC
    • KrioRus
    • Krystal Biotech
    • KuBio
    • Leica Biosystems
    • Life Sciences
    • Lion Biotechnologies
    • Living Cell Technologies
    • Lonza
    • McKinsey
    • Medical Devices
    • Medimmune
    • Medivation
    • MeiraGTx
    • Meissner
    • Merck
    • Mergers Partnerships & Acquisitions
    • Mersana Therapeutics
    • Mesoblast
    • Metagenomics
    • MilliporeSigma
    • Modular Factories
    • Molecular Pathology
    • Monsanto
    • Motif Bio
    • Mustang Bio
    • Myovant Sciences
    • Myriad Genetics
    • N4 Pharma
    • NantKwest
    • Natrix Separations
    • Navigo Proteins
    • Next Generation Sequencing
    • Nightstar Therapeutics
    • Ningbo Menovo
    • Northwest Biotherapeutics
    • Nortis
    • Novartis
    • Novo Nordisk
    • NuCana
    • Octapharma
    • Organovo
    • Orphazyme
    • Ovid Therapeutics
    • Oxford Genetics
    • Oxford Nanopore
    • Oxford University
    • Pacific Biosciences
    • Pall
    • Parexel
    • Patheon
    • PerkinElmer
    • Pfizer
    • Pharmaron
    • Plant Impact
    • PPD
    • Precision Medicine
    • Press Ganey
    • Prometic Bioseparations
    • Promore Pharma
    • Puridify
    • Qiagen
    • QuantiHealth
    • Quintiles IMS
    • RA Pharmaceuticals
    • Regenerative Medicine
    • Regeneron
    • Repligen
    • Roche
    • RTI Health Solutions
    • Samsung BioLogics
    • Sangamo Therapeutics
    • Saniona
    • Sanofi
    • Sartorius Stedim
    • Scandinavian Chemotech
    • Scarab Genomics
    • Seragon
    • Shire
    • Siegfried
    • Sienna Biopharmaceuticals
    • Sigma-Aldrich
    • Singulex
    • SkinBioTherapeutics
    • Spark Therapeutics
    • Spinout
    • Statis Systems
    • Stem Cells
    • StemoniX
    • Stempeutics
    • Sudhin Biopharma
    • Sunovion Pharma
    • Symphony Health Solutions
    • Syngenta
    • Synthon
    • SynVivo
    • Takara
    • Tanvex BioPharma
    • TARA
    • Telix Pharma
    • Terumo
    • Teva Pharmaceuticals
    • Texcell
    • The Cryonics Institute
    • The Future of BioManufacturing
    • Theranexus
    • Thermo Fisher Scientific
    • Thomson Reuters
    • TiGenix
    • Tocagen
    • TOSOH Bioscience
    • Touchstone Innovations
    • Toxicology
    • Truven
    • UCB Pharma
    • Urogen Pharma
    • Valbiotis
    • Valeant Pharmaceuticals
    • Venture Capital Investment
    • Vericel
    • Verona Pharma
    • Vetter
    • Virology
    • ViroMed
    • Vivo Science
    • Wacker
    • Waters
    • Woodford Fund
    • Wuxi Apptec
    • WuXi NextCODE
    • WuXi PharmaTech
    • Xbrane Biopharma
    • Xenotransplantation
    • Xspray Pharma
    • Zai Lab
    • Zealand Pharma
    • ZellWerk
    • Zymeworks
    Authors
    • evolution
    • evolutionbio
    Evolution Infographics
    2017 Global Therapeutic IPO Market: 121% YOY Increase in Funds Raised Despite Bearish Q3
    2017 Global Therapeutic IPO Market: 121% YOY Increase in Funds Raised Despite Bearish Q3
    More

    Search

    THE FUTURE OF BIOMANUFACTURING

    The Future of BioManufacturing

    Browse By Category

    Agricultural Technology Bioinformatics Biopharma Bioproduction Biotech Cancer Immunotherapy Cell Therapy Chemicals CRO/CMO Diagnostics Drug Development Gene Therapy Genomics & Proteomics Healthcare Analytics Informatics & Analytics Life Sciences Medical Devices Mergers Partnerships & Acquisitions Metagenomics Molecular Pathology Next Generation Sequencing Precision Medicine Regenerative Medicine Stem Cells The Future of BioManufacturing

    Browse By Company

    ACD Bio Agilent Technologies AstraZeneca Bayer Bio-Rad Bioinformatics bluebird bio Celgene Evolution Global Press Releases GE Healthcare GSK Illumina Johnson & Johnson Juno Therapeutics KITE Pharma Lonza Merck MilliporeSigma Novartis Pfizer Roche Sanofi Sartorius Stedim Sigma-Aldrich Thermo Fisher Scientific

    STOCK TICKER

    RECENT POSTS

    Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
    Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
    All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
    All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
    Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
    Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
    More Efficient and Affordable Large-Scale Biomanufacturing: Have Novo Nordisk Foundation Made a Major Breakthrough?
    More Efficient and Affordable Large-Scale Biomanufacturing: Have Novo Nordisk Foundation Made a Major Breakthrough?
    Global Drug Development IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017
    Global Drug Development IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017

    DATA VISUALISATION

    Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
    Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
    All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
    All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
    Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
    Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results

    About Us

    Evolution Bioscience is a global consultancy firm, specialising in market intelligence, strategy formulation, technology transfer and commercialisation services, covering the full range of Biotechnology sectors.

    Get In Touch

    +44 141 248 2026

    info@evolution-bio.com

    Recent Posts

    Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
    Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
    All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
    All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
    Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
    Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
    More Efficient and Affordable Large-Scale Biomanufacturing: Have Novo Nordisk Foundation Made a Major Breakthrough?
    More Efficient and Affordable Large-Scale Biomanufacturing: Have Novo Nordisk Foundation Made a Major Breakthrough?

    BROWSE NEWS BY INDUSTRY

    Agricultural Technology Biopharma Bioproduction Biotech Cancer Immunotherapy Cell Therapy Chemicals CRO/CMO Diagnostics Drug Development Gene Therapy Genomics & Proteomics Informatics & Analytics Life Sciences Medical Devices Mergers Partnerships & Acquisitions Metagenomics Next Generation Sequencing Regenerative Medicine The Future of BioManufacturing

    BROWSE NEWS BY COMPANY

    AstraZeneca Bayer Bio-Rad bluebird bio Celgene Evolution Global Press Releases GSK Illumina Juno Therapeutics KITE Pharma Lonza Merck MilliporeSigma Novartis Pfizer Roche Sanofi Sartorius Stedim Sigma-Aldrich Thermo Fisher Scientific
    2016 © Evolution Bioscience / Darwin Hutton Partners
    logo